# Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial

> **NCT07184307** · NA · RECRUITING · sponsor: **Benha University** · enrollment: 48 (estimated)

## Conditions studied

- Overactive Bladder Syndrome
- Urinary Urge Incontinence
- Detrusor Overactivity

## Interventions

- **BIOLOGICAL:** Platelet-Rich Plasma
- **DRUG:** Intravesical Botulinum Toxin Injection

## Key facts

- **NCT ID:** NCT07184307
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-15
- **Primary completion:** 2026-04-15
- **Final completion:** 2026-04-15
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07184307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07184307, "Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07184307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*